← Back to home

Newly diagnosed philadelphia (PH)-negative B-cell precursor acute lymphoblastic leukemia (ALL)

Clinical trials for Newly diagnosed philadelphia (PH)-negative B-cell precursor acute lymphoblastic leukemia (ALL) explained in plain language.

Never miss a new study

Get alerted when new Newly diagnosed philadelphia (PH)-negative B-cell precursor acute lymphoblastic leukemia (ALL) trials appear

Sign up with your email to follow new studies for Newly diagnosed philadelphia (PH)-negative B-cell precursor acute lymphoblastic leukemia (ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for older leukemia patients: targeted drug combo shows promise

Disease control Ongoing

This Phase 3 trial is testing whether a targeted immunotherapy drug called blinatumomab, given alongside low-intensity chemotherapy, works better than standard chemotherapy for older adults (55+) with a specific type of acute lymphoblastic leukemia (ALL). The study involves 303 p…

Matched conditions: NEWLY DIAGNOSED PHILADELPHIA (PH)-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

Phase 3 • Sponsor: Amgen • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

Newly diagnosed philadelphia (PH)-negative B-cell precursor acute lymphoblastic leukemia (ALL)

Get alerted when new Newly diagnosed philadelphia (PH)-negative B-cell precursor acute lymphoblastic leukemia (ALL) trials appear

New hope for older leukemia patients: targeted drug combo shows promise